Protecting The Public: Post Acute Medical Used IVP Biodefense System As Major COVID-19 Defense Before Vaccine Distribution Began

Post Acute Medical specialty hospitals utilized groundbreaking air purifying technology to prevent coronavirus infections.

Not too long ago, personal protective equipment was scarce, medical capacities were exhausted and a treatment to save the lives of coronavirus patients seemed out of reach. During this time, Post Acute Medical (PAM) turned to the IVP biodefense system to armor up against the novel virus. Since the beginning of the COVID-19 pandemic, PAM has invested in the most innovative defense mechanisms available to combat the spread of COVID-19 in our facilities and communities.

The first of its kind, the IVP biodefense system is equipped with air filtration technology that catches and destroys viruses of all types. It’s capable of eliminating 99.9% of coronavirus particles in the air among other airborne pathogens such as rhinovirus, anthrax and mold.

Before vaccines became available to the general public, PAM committed to taking every possible action to safeguard the health of our patients and staff. These efforts included a rollout of precautions in compliance with all CDC and federal health guidelines as well as the installation of IVP devices to select locations in our network of specialty hospitals across the United States.

With the IVP biodefense system installed in our facilities, PAM’s dedicated, highly trained medical staff continues to safely serve our patients with exceptional care. The IVP system played an essential role in our efforts to mitigate the spread of the virus, allowing health care workers and patients to regain confidence in receiving and administering care in a protected environment.

 

“As a leader in innovation among the health care industry, Post Acute Medical knew early on that waiting for a COVID-19 vaccine to be developed as a magic bullet solution wasn’t going to benefit us. We needed to take immediate action to quell the spread of the virus – beyond social distancing and PPE. The welfare of our patients depended on it,” said Anthony Misitano, President and CEO of Post Acute Medical. “We identified the IVP indoor biodefense system as a viable solution to ensure optimal air quality in our facilities and continue to install the system in our network of hospitals to provide an environment of continued safety and wellness to all.”

PAM is proud to lead the industry toward new standards of quality by embracing the latest cutting-edge health care technology.